Related references
Note: Only part of the references are listed.Viral Infections in Immunocompromised Patients
Janet Englund et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Targeting pandemic influenza: a primer on influenza antivirals and drug resistance
Ronald B. Moss et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo
Anne Moscona et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children
Jane Kuypers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: The role of community respiratory viruses
Veronique Erard et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection
MP Malakhov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
WG Nichols et al.
BLOOD (2001)
Medical progress - Respiratory syncytial virus and parainfluenza virus.
CB Hall
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Parainfluenza virus 3 infection after stem cell transplant: Relevance to outcome of rapid diagnosis and ribavirin treatment
J Elizaga et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
